REXULTI Trademark

Trademark Overview

On Monday, March 26, 2012, a trademark application was filed for REXULTI with the United States Patent and Trademark Office. The USPTO has given the REXULTI trademark a serial number of 79114561. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Friday, July 21, 2023. This trademark is owned by H. Lundbeck A/S. The REXULTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation and substances for the [ prevention and ] treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the [ prevention and ] treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the [ prevention and ] treatment of [ Alzheimer's disease, ] depression, psychosis, [ anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, ] and schizophrenia [, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes ]
rexulti

General Information

Serial Number79114561
Word MarkREXULTI
Filing DateMonday, March 26, 2012
Status706 - SECTION 71 ACCEPTED
Status DateFriday, July 21, 2023
Registration Number4287396
Registration DateTuesday, February 12, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparation and substances for the [ prevention and ] treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the [ prevention and ] treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the [ prevention and ] treatment of [ Alzheimer's disease, ] depression, psychosis, [ anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, ] and schizophrenia [, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 23, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressTokyo 1018535
JP
Party NameH. Lundbeck A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK
Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events

Event DateEvent Description
Friday, March 29, 2024INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, March 21, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 21, 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, July 21, 2023REGISTERED-SEC.71 ACCEPTED
Tuesday, July 18, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 2, 2023TEAS SECTION 71 RECEIVED
Thursday, April 14, 2022INTERNATIONAL REGISTRATION RENEWED
Saturday, February 12, 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, January 3, 2020PARTIAL INVALIDATION PROCESSED BY THE IB
Monday, November 18, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, November 18, 2019INVALIDATION PROCESSED
Saturday, October 26, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, February 26, 2019NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, February 26, 2019REGISTERED-SEC.71 ACCEPTED
Friday, February 8, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 1, 2019TEAS SECTION 71 RECEIVED
Monday, February 12, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, November 20, 2015NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 20, 2015CHANGE OF OWNER RECEIVED FROM IB
Thursday, June 12, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 12, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 23, 2013FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 23, 2013FINAL DISPOSITION PROCESSED
Sunday, May 12, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 12, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, November 27, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2012PUBLISHED FOR OPPOSITION
Monday, November 26, 2012NOTIFICATION PROCESSED BY IB
Wednesday, November 7, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 7, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 24, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 22, 2012ASSIGNED TO LIE
Tuesday, October 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 5, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 4, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 4, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 9, 2012REFUSAL PROCESSED BY IB
Friday, July 27, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 27, 2012REFUSAL PROCESSED BY MPU
Friday, July 27, 2012APPLICATION FILING RECEIPT MAILED
Thursday, July 26, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 25, 2012NON-FINAL ACTION WRITTEN
Monday, July 23, 2012ASSIGNED TO EXAMINER
Monday, July 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 20, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 19, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

rexulti substances pharmaceutical preparations nervous system disease central treatment prevention disorders